Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts

Exp Mol Med. 2010 Jan 31;42(1):38-46. doi: 10.3858/emm.2010.42.1.004.

Abstract

Cholesterol is one of major components of cell membrane and plays a role in vesicular trafficking and cellular signaling. We investigated the effects of cholesterol on matrix metalloproteinase-2 (MMP-2) activation in human dermal fibroblasts. We found that tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) expression and active form MMP-2 (64 kD) were dose-dependently increased by methyl-beta-cyclodextrin (MbetaCD), a cholesterol depletion agent. In contrast, cholesterol depletion-induced TIMP-2 expression and MMP-2 activation were suppressed by cholesterol repletion. Then we investigated the regulatory mechanism of TIMP-2 expression by cholesterol depletion. We found that the phosphorylation of JNK as well as ERK was significantly increased by cholesterol depletion. Moreover, cholesterol depletion-induced TIMP-2 expression and MMP-2 activation was significantly decreased by MEK inhibitor U0126, and JNK inhibitor SP600125, respectively. While a low dose of recombinant TIMP-2 (100 ng/ml) increased the level of active MMP-2 (64 kD), the high dose of TIMP-2 (>or=200 ng/ml) decreased the level of active MMP-2 (64 kD). Taken together, we suggest that the induction of TIMP-2 by cholesterol depletion leads to the conversion of proMMP-2 (72 kD) into active MMP-2 (64 kD) in human dermal fibroblasts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthracenes / pharmacology
  • Butadienes / pharmacology
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Cholesterol / metabolism
  • Cholesterol / physiology*
  • Cyclodextrins / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism*
  • Fibroblasts / ultrastructure
  • Humans
  • Immunoblotting
  • Immunoprecipitation
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • JNK Mitogen-Activated Protein Kinases / physiology
  • Matrix Metalloproteinase 2 / metabolism*
  • Microscopy, Electron, Transmission
  • Nitriles / pharmacology
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism*

Substances

  • Anthracenes
  • Butadienes
  • Cyclodextrins
  • Enzyme Inhibitors
  • Nitriles
  • U 0126
  • Tissue Inhibitor of Metalloproteinase-2
  • pyrazolanthrone
  • Cholesterol
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Matrix Metalloproteinase 2